VEDOLIZUMAB COMPARED WITH INFLIXIMAB FOR PERIANAL FISTULA CLOSURE IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE

被引：0
|
作者：
Gold, Stephanie
Cohen-Mekelburg, Shirley A.
Schneider, Yecheskel
Bosworth, Brian P.
Scherl, Ellen
Steinlauf, Adam F.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1725
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [21] Perianal Fistulas in Patients with Crohn's Disease: A direct Comparison of Vedolizumab Regimens
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (08): : 1188 - 1188
  • [22] Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
    Gu, Bonita
    Venkatesh, Kavya
    Williams, Astrid-Jane
    Ng, Watson
    Corte, Crispin
    Gholamrezaei, Ali
    Ghaly, Simon
    Xuan, Wei
    Paramsothy, Sudarshan
    Connor, Susan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (23) : 2597 - 2608
  • [23] HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE
    Gu, Bonita
    Venkatesh, Kavya
    Williams, Astrid-Jane
    Ng, Watson
    Corte, Crispin
    Simon, Ghaly
    Xuan, Wei
    Paramsothy, Sudarshan
    Connor, Susan J.
    GASTROENTEROLOGY, 2020, 158 (06) : S467 - S468
  • [24] Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
    Gu, B.
    Venkatesh, K.
    Williams, A. J.
    Ng, W.
    Corte, C.
    Ghaly, S.
    Xuan, W.
    Paramsothy, S.
    Connor, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S490 - S491
  • [25] Higher Infliximab Trough Levels Are Associated With a Higher Rate of Perianal Fistula Healing in Patients With Crohn's Disease
    Yarur, Andres
    Kanagala, Vikram
    Stein, Daniel
    Czul, Frank
    Agrawal, Dilpesh
    Zadvornova, Yelena
    Quintero, Maria A.
    Abreu, Maria T.
    GASTROENTEROLOGY, 2016, 150 (04) : S105 - S106
  • [26] Hospitalizations and Treatment Discontinuation among Patients with Ulcerative Colitis and Crohn's Disease Treated with Vedolizumab Compared with Infliximab
    Khalid, Javaria Mona
    Raluy-Callado, Mireia
    Alam, Naufi L.
    Wang, Rosa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S317 - S317
  • [27] Management of Perianal Fistula in Crohn's Disease
    Siemanowski, Ben
    Regueiro, Miguel
    INFLAMMATORY BOWEL DISEASES, 2008, 14 : S266 - S268
  • [28] Infliximab Treatment for Anal Fistula in Patients with Crohn's Disease
    Higashi, Daijiro
    Futami, Kitaro
    Egawa, Yuji
    Hirano, Kennji
    Tomiyasu, Takashige
    Ishibashi, Yukiko
    Simomura, Tamotsu
    Nii, Kaori
    Kuroki, Hirosuke
    Maekawa, Takafumi
    Ono, Yoichiro
    Matsui, Toshiyuki
    ANTICANCER RESEARCH, 2009, 29 (03) : 927 - 933
  • [29] Effect of Disease Location on Endoscopic and Radiographic Outcomes in Patients With Moderate to Severe Crohn's Disease Initiated on Vedolizumab
    Kashani, Amir
    Pabla, Baldeep S.
    Eaddy, Andre
    Scoville, Elizabeth
    Dalal, Robin
    Beaulieu, Dawn B.
    Schwartz, David A.
    Horst, Sara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S461 - S461
  • [30] EFFICACY OF SUBCUTANEOUS INFLIXIMAB IN PERIANAL CROHN'S DISEASE
    Smith, Philip J.
    Storey, Daniel
    Gregg, Belle
    Critchley, Lisa
    Stenson, June
    Bond, Ashley
    Steel, Alan
    Dibb, Martyn
    Collins, Paul
    Derbyshire, Edmund
    Probert, Christopher
    Subramanian, Sreedhar
    GUT, 2021, 70 : A91 - A92
12345